Patent intelligence · US
US 9211277
Dietary supplement composition
Dietary supplement composition
Patent details — US 9211277
- Jurisdiction
- US
- Status
- granted
- Grant date
- Dec 15, 2015
- Expiration
- Dec 10, 2035
- Applicant
- YOUNG LIVING ESSENTIAL OILS, LC
- Claims
- 20
- CPC classes
- A61K, A61K31/122, A61K31/202, A61K31/355
Quick answer
US 9211277 (Dietary supplement composition) is held by YOUNG LIVING ESSENTIAL OILS, LC. Status: granted. Granted Dec 15, 2015. Expires Dec 10, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- YOUNG LIVING ESSENTIAL OILS, LC
- Grant date
- Expiration
- Claims
- 20
- CPC classes
- A61K, A61K31/122, A61K31/202, A61K31/355, A61K31/592, A61K31/593
More from YOUNG LIVING ESSENTIAL OILS, LC
Related pharmaceutical patents in our USPTO index.
-
US 12419895
Methods for treating subjects with Prader-Willi syndrome
granted -
US 12350258
Compositions and methods for treatment of skin-related diseases and promoting dermatological health
granted -
US 12343348
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 12343381
Dosage regimen for pegylated interferon
granted -
US 12178823
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 12109216
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 12005081
Chimeric receptors and methods of use thereof
granted -
US 11884656
Pyrrole derivatives as PLK1 inhibitors
granted
Frequently asked questions
What is US patent 9211277?
US 9211277 (Dietary supplement composition) is held by YOUNG LIVING ESSENTIAL OILS, LC. Status: granted. Granted Dec 15, 2015. Expires Dec 10, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9211277?
YOUNG LIVING ESSENTIAL OILS, LC is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 95 pharmaceutical patents for this assignee.
When does US 9211277 expire?
Our index shows an expiration date of Dec 10, 2035 (9 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.